Figure 1From: Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer Study design and treatment schedule. EGFR, epidermal growth factor receptor; PR, partial response; SD, stable disease.Back to article page